IPHA – innate pharma s.a. - american depositary shares (US:NASDAQ)

News

Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Innate Pharma GAAP EPS of -€0.55, revenue of €9.01M [Seeking Alpha]
Innate Pharma Reports Full Year 2025 Financial Results and Business Update [Yahoo! Finance]
Innate Pharma Reports Full Year 2025 Financial Results and Business Update
Innate Pharma (IPHA) was upgraded by BTIG Research to "strong-buy".
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com